Cargando…

2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study

BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Mellis, Alexandra, Smith-Jeffcoat, Sarah E, Petrie, Joshua, Keipp Talbot, H, Morrissey, Kerry Grace, Stockwell, Melissa, Maldonado, Yvonne A, Bowman, Natalie M, Lutrick, Karen, Rao, Suchitra, Salvatore, Phillip P, Biddle, Jessica E, Olivo, Vanessa, Battan-Wraith, Steph, Merrill, Lori S, McLaren, Son H, Sano, Ellen, Diaz, Anny, Sarnquist, Clea, Govindaranjan, Prasanthi, Goodman, Sara H, Ellingson, Katherine, Ledezma, Karla I, Pryor, Kathleen, Lin, Jessica T, Bullock, Ayla, Yang, Amy, Belongia, Edward, McLean, Huong, Asturias, Edwin J, Izurieta, Hector, Hart, Kimberly W, Schmitz, Jonathan, Zhu, Yuwei, Rolfes, Melissa A, Grijalva, Carlos G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678927/
http://dx.doi.org/10.1093/ofid/ofad500.1924
_version_ 1785150472547467264
author Mellis, Alexandra
Smith-Jeffcoat, Sarah E
Petrie, Joshua
Keipp Talbot, H
Morrissey, Kerry Grace
Stockwell, Melissa
Maldonado, Yvonne A
Bowman, Natalie M
Lutrick, Karen
Rao, Suchitra
Salvatore, Phillip P
Biddle, Jessica E
Olivo, Vanessa
Battan-Wraith, Steph
Merrill, Lori S
McLaren, Son H
Sano, Ellen
Diaz, Anny
Sarnquist, Clea
Govindaranjan, Prasanthi
Goodman, Sara H
Ellingson, Katherine
Ledezma, Karla I
Pryor, Kathleen
Lin, Jessica T
Bullock, Ayla
Yang, Amy
Belongia, Edward
McLean, Huong
Asturias, Edwin J
Izurieta, Hector
Hart, Kimberly W
Schmitz, Jonathan
Zhu, Yuwei
Rolfes, Melissa A
Grijalva, Carlos G
author_facet Mellis, Alexandra
Smith-Jeffcoat, Sarah E
Petrie, Joshua
Keipp Talbot, H
Morrissey, Kerry Grace
Stockwell, Melissa
Maldonado, Yvonne A
Bowman, Natalie M
Lutrick, Karen
Rao, Suchitra
Salvatore, Phillip P
Biddle, Jessica E
Olivo, Vanessa
Battan-Wraith, Steph
Merrill, Lori S
McLaren, Son H
Sano, Ellen
Diaz, Anny
Sarnquist, Clea
Govindaranjan, Prasanthi
Goodman, Sara H
Ellingson, Katherine
Ledezma, Karla I
Pryor, Kathleen
Lin, Jessica T
Bullock, Ayla
Yang, Amy
Belongia, Edward
McLean, Huong
Asturias, Edwin J
Izurieta, Hector
Hart, Kimberly W
Schmitz, Jonathan
Zhu, Yuwei
Rolfes, Melissa A
Grijalva, Carlos G
author_sort Mellis, Alexandra
collection PubMed
description BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 2023. The household primary case was the person with the earliest symptom onset or positive test. Starting ≤6 days after primary case onset, primary cases and HHC completed symptom logs (daily, retrospective since onset and for 10 days post-enrollment) and collected nasal or saliva specimens (daily for 10 days) that were tested by RT-PCR. Infected individuals were counted as having developed fever, lower respiratory symptoms (LRS: wheezing, chest tightness/pain, shortness of breath, cough), other symptoms (fatigue, aches, abdominal pain, diarrhea, vomiting, change of taste/smell, headache, sore throat, runny nose, nasal congestion), or as being asymptomatic based on all logs. Risk of secondary infection (any PCR positivity) among eligible, tested HHC (Methods 1) by symptoms of primary cases was estimated using Poisson regression with generalized estimating equations. We estimated days from onset to last PCR positive in a survival model. Methods upload 1. Enrolled and analytically included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sept 2021 - Mar 2023. [Figure: see text] RESULTS: This analysis included 842 households (839 primary cases, 836 infected HHC, and 615 uninfected HHC, median household size of 2). Most primary cases (99%) and infected HHC (81%) were symptomatic (Results 1). Primary cases had higher frequencies of fever or LRS than infected HHC (Results 2). HHC exposed to primary cases who developed fever or LRS were more likely to become infected than HHC exposed to primary cases who did not have fever or LRS (Results 3). Post-hoc comparisons by individual symptoms supported this for fever and all LRS but chest pain (fever: IRR 1.31 95% CI: 1.13-1.52; cough: IRR 1.54 95% CI 1.21 – 1.95; wheezing: IRR 1.20 95% CI 1.08 – 1.35; shortness of breath IRR 1.15, 95% CI 1.04 – 1.27). Primary cases with fever or LRS were PCR positive for a median of 14 days (95% CI: 14 – 15) post-onset, compared to 10 days (95% CI: 9 – 11) for cases who did not have fever or LRS. Results upload 1. Characteristics of included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sep 2021 - Mar 2023. [Figure: see text] Results upload 2. Proportion of primary cases and infected household contacts who experienced individual symptoms. [Figure: see text] Results upload 3. Unadjusted and adjusted risk of household contacts becoming infected with SARS-CoV-2, by symptoms in the primary case. [Figure: see text] CONCLUSION: Contacts of primary cases with fever or lower respiratory symptoms may have been more likely to become infected than contacts of primary cases without, suggesting higher transmissibility. DISCLOSURES: Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support Yvonne A. Maldonado, MD, Pfizer: Grant/Research Support|Pfizer: Site Investigator, DSMB member Suchitra Rao, MBBS, MSCS, Sequiris: Advisor/Consultant Edward Belongia, MD, Seqirus: Grant/Research Support Huong McLean, PhD, MPH, Seqirus: Grant/Research Support Edwin J. Asturias, MD, Hillevax: Advisor/Consultant|Moderna: Advisor/Consultant|Pfizer: Grant/Research Support Carlos G. Grijalva, MD, MPH, AHRQ: Grant/Research Support|CDC: Grant/Research Support|FDA: Grant/Research Support|Merck: Advisor/Consultant|NIH: Grant/Research Support|Syneos Health: Grant/Research Support
format Online
Article
Text
id pubmed-10678927
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106789272023-11-27 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study Mellis, Alexandra Smith-Jeffcoat, Sarah E Petrie, Joshua Keipp Talbot, H Morrissey, Kerry Grace Stockwell, Melissa Maldonado, Yvonne A Bowman, Natalie M Lutrick, Karen Rao, Suchitra Salvatore, Phillip P Biddle, Jessica E Olivo, Vanessa Battan-Wraith, Steph Merrill, Lori S McLaren, Son H Sano, Ellen Diaz, Anny Sarnquist, Clea Govindaranjan, Prasanthi Goodman, Sara H Ellingson, Katherine Ledezma, Karla I Pryor, Kathleen Lin, Jessica T Bullock, Ayla Yang, Amy Belongia, Edward McLean, Huong Asturias, Edwin J Izurieta, Hector Hart, Kimberly W Schmitz, Jonathan Zhu, Yuwei Rolfes, Melissa A Grijalva, Carlos G Open Forum Infect Dis Abstract BACKGROUND: Understanding the transmissibility of respiratory viruses by symptoms is important for public health. METHODS: Persons who tested positive for SARS-CoV-2 and their household contacts (HHC) were recruited from 7 US sentinel sites or by remote invitation nationwide during Sep. 2021—Mar. 2023. The household primary case was the person with the earliest symptom onset or positive test. Starting ≤6 days after primary case onset, primary cases and HHC completed symptom logs (daily, retrospective since onset and for 10 days post-enrollment) and collected nasal or saliva specimens (daily for 10 days) that were tested by RT-PCR. Infected individuals were counted as having developed fever, lower respiratory symptoms (LRS: wheezing, chest tightness/pain, shortness of breath, cough), other symptoms (fatigue, aches, abdominal pain, diarrhea, vomiting, change of taste/smell, headache, sore throat, runny nose, nasal congestion), or as being asymptomatic based on all logs. Risk of secondary infection (any PCR positivity) among eligible, tested HHC (Methods 1) by symptoms of primary cases was estimated using Poisson regression with generalized estimating equations. We estimated days from onset to last PCR positive in a survival model. Methods upload 1. Enrolled and analytically included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sept 2021 - Mar 2023. [Figure: see text] RESULTS: This analysis included 842 households (839 primary cases, 836 infected HHC, and 615 uninfected HHC, median household size of 2). Most primary cases (99%) and infected HHC (81%) were symptomatic (Results 1). Primary cases had higher frequencies of fever or LRS than infected HHC (Results 2). HHC exposed to primary cases who developed fever or LRS were more likely to become infected than HHC exposed to primary cases who did not have fever or LRS (Results 3). Post-hoc comparisons by individual symptoms supported this for fever and all LRS but chest pain (fever: IRR 1.31 95% CI: 1.13-1.52; cough: IRR 1.54 95% CI 1.21 – 1.95; wheezing: IRR 1.20 95% CI 1.08 – 1.35; shortness of breath IRR 1.15, 95% CI 1.04 – 1.27). Primary cases with fever or LRS were PCR positive for a median of 14 days (95% CI: 14 – 15) post-onset, compared to 10 days (95% CI: 9 – 11) for cases who did not have fever or LRS. Results upload 1. Characteristics of included household members in case-ascertained studies of household transmission of SARS-CoV-2, United States, Sep 2021 - Mar 2023. [Figure: see text] Results upload 2. Proportion of primary cases and infected household contacts who experienced individual symptoms. [Figure: see text] Results upload 3. Unadjusted and adjusted risk of household contacts becoming infected with SARS-CoV-2, by symptoms in the primary case. [Figure: see text] CONCLUSION: Contacts of primary cases with fever or lower respiratory symptoms may have been more likely to become infected than contacts of primary cases without, suggesting higher transmissibility. DISCLOSURES: Joshua Petrie, PhD, CSL Seqirus: Grant/Research Support Yvonne A. Maldonado, MD, Pfizer: Grant/Research Support|Pfizer: Site Investigator, DSMB member Suchitra Rao, MBBS, MSCS, Sequiris: Advisor/Consultant Edward Belongia, MD, Seqirus: Grant/Research Support Huong McLean, PhD, MPH, Seqirus: Grant/Research Support Edwin J. Asturias, MD, Hillevax: Advisor/Consultant|Moderna: Advisor/Consultant|Pfizer: Grant/Research Support Carlos G. Grijalva, MD, MPH, AHRQ: Grant/Research Support|CDC: Grant/Research Support|FDA: Grant/Research Support|Merck: Advisor/Consultant|NIH: Grant/Research Support|Syneos Health: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10678927/ http://dx.doi.org/10.1093/ofid/ofad500.1924 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Mellis, Alexandra
Smith-Jeffcoat, Sarah E
Petrie, Joshua
Keipp Talbot, H
Morrissey, Kerry Grace
Stockwell, Melissa
Maldonado, Yvonne A
Bowman, Natalie M
Lutrick, Karen
Rao, Suchitra
Salvatore, Phillip P
Biddle, Jessica E
Olivo, Vanessa
Battan-Wraith, Steph
Merrill, Lori S
McLaren, Son H
Sano, Ellen
Diaz, Anny
Sarnquist, Clea
Govindaranjan, Prasanthi
Goodman, Sara H
Ellingson, Katherine
Ledezma, Karla I
Pryor, Kathleen
Lin, Jessica T
Bullock, Ayla
Yang, Amy
Belongia, Edward
McLean, Huong
Asturias, Edwin J
Izurieta, Hector
Hart, Kimberly W
Schmitz, Jonathan
Zhu, Yuwei
Rolfes, Melissa A
Grijalva, Carlos G
2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title_full 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title_fullStr 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title_full_unstemmed 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title_short 2302. Transmissibility of SARS-CoV-2 by symptom: data from a case-ascertained household transmission study
title_sort 2302. transmissibility of sars-cov-2 by symptom: data from a case-ascertained household transmission study
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678927/
http://dx.doi.org/10.1093/ofid/ofad500.1924
work_keys_str_mv AT mellisalexandra 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT smithjeffcoatsarahe 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT petriejoshua 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT keipptalboth 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT morrisseykerrygrace 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT stockwellmelissa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT maldonadoyvonnea 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT bowmannataliem 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT lutrickkaren 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT raosuchitra 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT salvatorephillipp 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT biddlejessicae 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT olivovanessa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT battanwraithsteph 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT merrillloris 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT mclarensonh 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT sanoellen 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT diazanny 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT sarnquistclea 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT govindaranjanprasanthi 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT goodmansarah 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT ellingsonkatherine 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT ledezmakarlai 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT pryorkathleen 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT linjessicat 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT bullockayla 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT yangamy 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT belongiaedward 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT mcleanhuong 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT asturiasedwinj 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT izurietahector 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT hartkimberlyw 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT schmitzjonathan 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT zhuyuwei 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT rolfesmelissaa 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy
AT grijalvacarlosg 2302transmissibilityofsarscov2bysymptomdatafromacaseascertainedhouseholdtransmissionstudy